retatrutide not dissolving Unapproved weight loss drug causes extreme side effects Retatrutide Side Effects Guide: 21

Are GLP-1s new medications

Participants first completed 36 weeks of tirzepatide treatment, losing an average of 20.9% of their body weight

Retatrutide is still in clinical development and is not broadly approved as a standard treatment

Additional Resources Phentermine: A prescription drug for weight-loss OPSS Berberine: The hype for Natures Ozempic OPSS Weight-loss dietary supplements: What you should know OPSS Posted 3 June 2026

42 While the exact mechanisms are not fully understood, imaging studies suggest that reductions in upper airway adiposity, particularly tongue fat, may contribute to these improvements